SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

ADC Therapeutics SA
Date: July 7, 2025 · CIK: 0001771910 · Accession: 0000950103-25-008512

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-288437

Date
July 7, 2025
Author
ADC Therapeutics SA
Form
CORRESP
Company
ADC Therapeutics SA

Letter

Re: ADC Therapeutics SA Registration Statement on Form S-3 Registration No. 333-288437

July 7, 2025

VIA EDGAR

Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (File No. 333-288437) (the "Registration Statement") of ADC Therapeutics SA. We respectfully request that the Registration Statement be declared effective as of 4:00 p.m., Eastern time, on July 9, 2025, or as soon as practicable thereafter.

Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Davis Polk & Wardwell LLP, by calling David Li at (212) 450-3861.

Thank you for your assistance in this matter.

Sincerely,
ADC Therapeutics SA

Show Raw Text
CORRESP
 1
 filename1.htm

 July 7, 2025

 VIA EDGAR

 Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549

 Re:
 ADC Therapeutics SA
Registration Statement on Form S-3
Registration No. 333-288437

 Ladies and Gentlemen:

 In accordance with Rule 461 under the Securities Act of 1933, as amended,
we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (File No. 333-288437) (the "Registration
Statement") of ADC Therapeutics SA. We respectfully request that the Registration Statement be declared effective as of 4:00 p.m.,
Eastern time, on July 9, 2025, or as soon as practicable thereafter.

 Once the Registration Statement has been declared effective, please
orally confirm that event with our counsel, Davis Polk & Wardwell LLP, by calling David Li at (212) 450-3861.

 Thank you for your assistance in this matter.

 Sincerely,

 ADC Therapeutics SA

 By:
 /s/ Peter J. Graham

 Name:	Peter J. Graham

 Title:	Chief Legal Officer